PO32 Phytochemical study of Siparuna gesnerioides and its antiviral activity against SARS-CoV-2
DOI:
https://doi.org/10.3407/hmp1mc74Keywords:
Siparunaceae, Siparuna gesnerioides, Countercurrent Chromatography, Nuclear Magnetic Resonance, Antiviral Potential for Covid-19.Abstract
Species of the genus Siparuna (Siparunaceae) are popularly recognized for their anxiolytic, antioxidant, and antiviral properties1,2.
The most active extract was purified by countercurrent chromatography (CCC) using an HTPrep system equipped with a 112 mL column, using a hexane-ethyl acetate-methanol-water solvent system in the ratios 3:7:5:5 and 5:5:5:5 v/v. TFraction XIII was selected for purification, allowing the identification of the flavonoid 3,7-di-O-methyl-kaempferol (kumatakenin). The extract showed a 54% inhibition of the SARS-CoV-2 RBD:ACE2 interaction and a 92% inhibition in the PL pro and 3CLpro assays.
References
[1] LEITÃO, G. G., et al. (2000). Kaempferol Glycosides from Siparuna Apiosyce. Phytochemistry 55(6): 679-682. [DOI]
[2] LEAL, C. M., et al. (2022). Bioassay-Guided Fractionation of Siparuna Glycycarpa n-Butanol Extract with Inhibitory Activity against Influenza A(H1N1)Pdm09 Virus by Centrifugal Partition Chromatography (CPC). Molecules 27(2). [DOI]
[3] GONZALEZ, J. E. A., et al. (2022). Aislamiento, Caracterización y Evaluación de los Aceites Esenciales de Siparuna gesnerioides (Kunth) A. DC., como Agente Antimicrobiano contra Salmonella spp. Revista Productos Naturales, 5(2), 179-181. [DOI]
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Jhon F. Castañeda-Goméz, Gilda G. Leitão, Dra. Suzana G. Leitão, Dr. Diego Allonso, Dra. Thamires Fonseca, Dra. Mariana Campos, Dra. Simoni Mendoca, Dra. Esthella Silva, Nayara Sales, Dra. Diegina Fernándes

This work is licensed under a Creative Commons Attribution 4.0 International License.
License Terms
The Creative Commons Attribution License (CC BY 4.0) allows users to copy, distribute and transmit an article and adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity.